Table 2 Treatment modality and prognostic outcome between Jewish and Bedouin patients for early-stage disease. SD, standard deviation
|  | All N = 1476 | Jewish N = 1302 | Bedouin N = 155 | p value |
|---|---|---|---|---|
Median follow-up, months (SD) | 53.2 (33.5) | 57.2 (13.1) | 53 (14.3) | 0.152 |
Surgery, n (%) | 1368 | 1217 (93.5%) | 151 (97.4%) | 0.051 |
Chemo, n (%) | 595 | 506 (39.1%) | 89 (57.4%) | < 0.001 |
Systemic Neoadjuvant, n (%) | 371 | 301 (23.3%) | 70 (45.2%) | < 0.001 |
Adjuvant Radiotherapy, n (%) | 1098 | 965 (74.6%) | 133 (85.8%) | 0.001 |
Hormonal, n (%) | 1098 | 976 (75.7%) | 122 (78.7%) | 0.428 |
Recurrence, n (%) | 248 | 216 (16.6%) | 32(20.6%) | 0.214 |